bluebird bio, Inc. Purchase Agreements
7 Contracts & Agreements
- Invoice Purchase and Sale Agreement, dated as of December 14, 2023, by and between bluebird bio, Inc. and Alterna Capital Solutions LLC (Filed With SEC on December 18, 2023)
- Asset Purchase Agreement, dated as of October 26, 2023, by and between bluebird bio, Inc. and Novartis Pharma AG (Filed With SEC on October 30, 2023)
- Asset Purchase Agreement, dated as of January 5, 2023, by and between bluebird bio, Inc. and Bristol-Myers Squibb Company (Filed With SEC on January 6, 2023)
- Asset Purchase Agreement, dated as of November 29, 2022, by and between bluebird bio, Inc. and argenx BV (Filed With SEC on November 30, 2022)
- Securities Purchase Agreement, dated September 7, 2021, by and among the Registrant and the institutional investors named therein (Filed With SEC on November 5, 2021)
- Securities Purchase Agreement, dated September 7, 2021, by and among the Company and the institutional investors named therein (Filed With SEC on September 8, 2021)
- BLUEBIRD BIO, INC. 2013 EMPLOYEESTOCK PURCHASE PLAN (Filed With SEC on June 4, 2013)